Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05591859 · ClinicalTrials.gov registry record · NA

Restoration Anatomic Acetabular Shell Revision Study

A NA study of Hip Osteoarthritis and Hip Arthropathy, sponsored by Stryker Orthopaedics.

Recruiting
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT05591859 is a NA study of Hip Osteoarthritis and Hip Arthropathy that is actively recruiting participants, run by Stryker Orthopaedics. The registered enrollment target is 56 participants, below the 400-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05591859, a NA study of Hip Osteoarthritis and Hip Arthropathy, is actively recruiting participants, sponsored by Stryker Orthopaedics.

RECRUITING
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

This study will be a non-randomized, ambidirectional (retrospective and prospective) study where all subjects will be followed prospectively. The study will evaluate the survivorship of the RAS acetabular component in a previously failed total hip arthroplasty (THA) in a consecutive series of subjects who meet the eligibility criteria.

Interventions

  • DEVICE Restoration Anatomic Acetabular Shell

Study Locations (1)

Colorado

  • Regents of the University of Colorado - Denver

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2024-03-02
Est. Completion 2036-03-01
Phase NA

Sponsor

Stryker Orthopaedics

27 total trials

What the Registry Record Tells You About NCT05591859

The ClinicalTrials.gov registry entry for NCT05591859 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 400-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (86% lower). The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hip Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Restoration Anatomic Acetabular Shell is the first listed.

NCT05591859 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05591859 about?

NCT05591859 is a clinical study titled "Restoration Anatomic Acetabular Shell Revision Study". This study will be a non-randomized, ambidirectional (retrospective and prospective) study where all subjects will be followed prospectively. The study will evaluate the survivorship of the RAS acetabular component in a previously failed total hip arthroplasty (THA) in a consecutive series of subjec...

What is the current status of trial NCT05591859?

This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2024-03-02. Estimated completion is 2036-03-01.

What conditions does trial NCT05591859 study?

This clinical trial studies the following conditions: Hip Osteoarthritis, Hip Arthropathy, Arthropathy.

What interventions are being tested in trial NCT05591859?

The interventions under investigation include: Restoration Anatomic Acetabular Shell (DEVICE).

Who is sponsoring clinical trial NCT05591859?

This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05591859 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.